Lupin gets USFDA nod for generic contraceptive tablets

The company has received final approval from the US Food and Drug Administration (USFDA) to market Tydemy, which is a generic version of Bayer HealthCare Pharmaceuticals' Safyral Tablets, Lupin said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news